HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 21477690, compound → HCID 21477641, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | HCID 21477690 | HCID 21477690 | — |
| Reactant | HCID 86750277 | HCID 86750277 | — |
| Product | HCID 21477641 | HCID 21477641 | — |
Reaction Steps
Following the general procedure of EXAMPLE 32, and making non-critical variations but substituting 1-[5-(2-phthalimidoethanesulfonamido)indole-2-carbonyl]-4-[3-(1-methylethylamino)-2-pyridinyl]piperazine (EXAMPLE 33, 605 mg) for 1-[5-(2-(phthalimidoethanesulfonamido)indole -2-carbonyl]-4-[N -methyl-N-(3-(1-methylethylamino)-2pyridinyl)amino]-piperidine, the title compound is obtained, NMR (CDCl3) 10.62, 7.68, 7.55, 7.25, 7.07, 6.93, 6.84, 6.69, 4.20, 4.04, 3.90-3.50, 3.14 and 1.25 δ.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US05599930 |
| Source dataset | uspto-grants-1997_02 |
| ORD ID | ord-42ce2eafe0974ff29dd0539db9933618 |
| Source note | uspto-grants-1997_02 |